U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07791030) titled 'Diagnostic and Prognostic Roles of Procalcitonin and Highly Sensitive C-Reactive Protein in Early Detection of Burn Sepsis' on Aug. 24.
Brief Summary: This study aimed to evaluate the value of procalcitonin and highly sensitive c-reactive protein as biomarkers for early detection of sepsis in patients with major burns.
Study Start Date: Sept. 01, 2025
Study Type: OBSERVATIONAL
Condition:
Diagnostic Role
Prognostic Role
Procalcitonin
Highly Sensitive
C-Reactive Protein
Early Detection
Burn Sepsis
Intervention:
DIAGNOSTIC_TEST: Measurement of Procalcitonin level
Two samples was collected from each patient, one on admission or w...